S Watson Selected Research

1-methylpropyl-2-imidazolyl disulfide

9/2000

Antitumor imidazolyl disulfide IV-2 causes irreversible G(2)/M cell cycle arrest without hyperphosphorylation of cyclin-dependent kinase Cdk1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Watson Research Topics

Disease

5	Neoplasms (Cancer) 09/2019 - 07/2000
4	Adenocarcinoma 09/2019 - 12/2010
3	Coronary Disease (Coronary Heart Disease) 04/2009 - 01/2007
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2008 - 04/2001
2	Wounds and Injuries (Trauma) 12/2015 - 01/2001
2	Pain (Aches) 08/2013 - 01/2000
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2007 - 01/2007
2	Burns 11/2003 - 01/2000
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2003 - 01/2001
1	Sarcoma (Soft Tissue Sarcoma) 12/2020
1	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 06/2019
1	Pseudoainhum 06/2019
1	digital ulcers 05/2019
1	Systemic Scleroderma (Systemic Sclerosis) 05/2019
1	Nausea 01/2019
1	Febrile Neutropenia 01/2019
1	Obesity 05/2017
1	Digital Dermatitis 06/2012
1	Colorectal Neoplasms (Colorectal Cancer) 06/2011
1	Neoplasm Metastasis (Metastasis) 06/2011
1	Medulloblastoma 12/2010
1	Basal Cell Carcinoma (Rodent Ulcer) 12/2010
1	von Willebrand Diseases (von Willebrand's Disease) 01/2010
1	Hemorrhage 01/2010
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2010
1	Mood Disorders (Mood Disorder) 01/2008
1	Ischemic Stroke 02/2007
1	Vascular Diseases (Vascular Disease) 02/2007
1	Neuromuscular Diseases (Neuromuscular Disease) 04/2004
1	Constipation 04/2004
1	Muscle Hypotonia (Hypotonia) 04/2004
1	Necrotizing Fasciitis 11/2003
1	Lacerations 11/2003
1	Parkinson Disease (Parkinson's Disease) 02/2003
1	Postoperative Pain 07/2002
1	Keratoconjunctivitis 04/2002
1	Anxiety Disorders (Anxiety Disorder) 08/2001
1	Neutropenia 01/2001
1	Stroke (Strokes) 08/2000
1	Sezary Syndrome (Sezary Erythroderma) 07/2000

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2010 - 07/2000
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2019 - 01/2019
2	Fluorouracil (Carac)FDA LinkGeneric 09/2019 - 01/2019
2	130-nm albumin-bound paclitaxelIBA 09/2019 - 01/2019
1	pazopanib FDA Link 12/2020
1	crenigacestatIBA 12/2020
1	loricrinIBA 06/2019
1	PlatinumIBA 01/2019
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 12/2015
1	Trastuzumab (Herceptin)FDA Link 12/2013
1	SteroidsIBA 08/2013
1	Copper Sulfate (Sulfate, Copper)FDA Link 06/2012
1	integrin-linked kinaseIBA 06/2011
1	Calcibiotic Root Canal SealerIBA 06/2011
1	Fibrinogen (Factor I)FDA Link 04/2009
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2008
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 02/2007
1	LipidsIBA 01/2007
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2006
1	Tiagabine (Gabitril)FDA Link 07/2006
1	antineoplaston A10 (A 10)IBA 04/2004
1	CalciumIBA 04/2004
1	Dopamine (Intropin)FDA LinkGeneric 02/2003
1	Yohimbine (Yocon)IBA 08/2001
1	ElementsIBA 04/2001
1	Topoisomerase I InhibitorsIBA 01/2001
1	9-aminocamptothecinIBA 01/2001
1	Alfentanil (Alfenta)FDA LinkGeneric 01/2001
1	ThioredoxinsIBA 09/2000
1	1-methylpropyl-2-imidazolyl disulfideIBA 09/2000
1	IntegrinsIBA 08/2000
1	Monoclonal AntibodiesIBA 07/2000
1	DNA (Deoxyribonucleic Acid)IBA 07/2000

Therapy/Procedure

3	Therapeutics 05/2010 - 01/2001
2	Skin Transplantation (Skin Grafting) 06/2019 - 11/2003
2	Analgesia 01/2001 - 01/2000
1	Low-Level Light Therapy (LLLT) 05/2019
1	Neoadjuvant Therapy 01/2019
1	Drug Therapy (Chemotherapy) 01/2019
1	Esophagectomy 05/2017
1	Injections 08/2013
1	Molecular Targeted Therapy 12/2010
1	Tonsillectomy 07/2002
1	Contact Lenses 04/2002
1	Bandages (Bandage) 04/2002